Search

Displaying results 5211 - 5220 of 7479 in total
  1. Drug

    Metamfazone

    go.drugbank.com/drugs/DB20145
    Experimental

    Metamfazone has a monoisotopic molecular weight of 201.09 Da.

  2. Drug

    Depramine

    go.drugbank.com/drugs/DB20198
    Experimental

    Depramine has a monoisotopic molecular weight of 278.18 Da.

  3. Drug

    Ramorelix

    go.drugbank.com/drugs/DB20209
    Experimental

    Ramorelix has a monoisotopic molecular weight of 1530.67 Da.

  4. Drug

    Ftaxilide

    go.drugbank.com/drugs/DB20254
    Experimental

    Ftaxilide has a monoisotopic molecular weight of 269.11 Da.

  5. Drug

    Ipenoxazone

    go.drugbank.com/drugs/DB20277
    Experimental

    Ipenoxazone has a monoisotopic molecular weight of 358.26 Da.

  6. Drug

    Pirbenicillin

    go.drugbank.com/drugs/DB20321
    Experimental

    Pirbenicillin has a monoisotopic molecular weight of 510.17 Da.

  7. Drug

    Umeclidinium

    go.drugbank.com/drugs/DB09076
    ApprovedInvestigational

    Umeclidinium is a long-acting muscarinic antagonist (LAMA) used as a maintenance treatment for symptoms of chronic obstructive pulmonary disease (COPD). COPD is a progressive obstructive lung disease characterized by shortness of breath,...

  8. Drug

    Loracarbef

    go.drugbank.com/drugs/DB00447
    ApprovedWithdrawn

    Loracarbef is a carbacephem antibiotic sometimes grouped together with the second-generation cephalosporin antibiotics. It is marketed under the trade name Lorabid.

  9. Drug

    Selexipag

    go.drugbank.com/drugs/DB11362
    ApprovedInvestigational

    Selexipag was approved by the United States FDA on December 22, 2015 for the treatment of pulmonary arterial hypertension (PAH) to delay disease progression and reduce risk of hospitalization. PAH is a relatively rare disease with usuall...

  10. Drug

    Plecanatide

    go.drugbank.com/drugs/DB13170
    ApprovedInvestigational

    Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). It should not be used in children less than six years of age, and should be avoided in patients six years to 18 years o...